24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      In vitro expression of cytokeratin 18, 19 and tube formation of adipose‐derived stem cells induced by the breast epithelial cell line HBL‐100

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Fat transplantation is increasingly used in breast augmentation; and recently, the issue of safety concerns from a cellular and molecular point of view has been raised. In this study, attentions were paid to the interaction between adipose‐derived stem cells ( ADSC) and mammary epithelial cells: human breast cancer cell line ‐ 100 (HBL ‐ 100) cells were used to simulate the normal microenvironment in breast tissue, ADSCs were harvest from human and co‐cultured with HBL‐100 cells. It was found that ADSCs formed tube‐like structures in the co‐culture with HBL‐100 cells in contrast to the normal morphology of ADSCs in the control group. In addition, the immunofluorescence imaging showed that cytokeratin 18 and 19 ( CK18 and 19) were significantly expressed in ADSCs after the co‐culture with HBL‐100 cells. The ultrastructure of those ADSCs also showed epithelial changes. In conclusion, ADSCs are not biological stable when co‐cultured with HBL‐100 cells. They differentiate into epithelial‐like cells with the expression of epithelial surface marks ( CK 18, 19) and form tube‐like structures. This may offer an important evidence for the further study of clinical application of transplanting ADSCs rich adipose tissue into the breast in the future.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Fat grafting to the breast revisited: safety and efficacy.

          A 1987 American Society of Plastic and Reconstructive Surgeons position paper predicted that fat grafting would compromise breast cancer detection and should therefore be prohibited. However, there is no evidence that fat grafting to breasts is less safe than any other form of breast surgery. As discussions of fat grafting to the breast are surfacing all over the world, it is time to reexamine the opinions of the 1987 American Society of Plastic and Reconstructive Surgeons position paper. This is a retrospective examination of 17 breast procedures performed using fat grafting from 1995 to 2000. Indications included micromastia, postaugmentation deformity, tuberous breast deformity, Poland's syndrome, and postmastectomy reconstruction deformities. The technique used was the Coleman method of fat grafting, which attempts to minimize trauma and place grafted fat in small aliquots at many levels. All women had a significant improvement in their breast size and/or shape postoperatively and all had breasts that were soft and natural in appearance and feel. Postoperative mammograms identified changes one would expect after any breast procedure. Given these results and reports of other plastic surgeons, free fat grafting should be considered as an alternative or adjunct to breast augmentation and reconstruction procedures. It is time to end the discrimination created by the 1987 position paper and judge fat grafting to the breast with the same caution and enthusiasm as any other useful breast procedure.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer.

            Among the many different cell types surrounding breast cancer cells, the most abundant are those that compose mammary adipose tissue, mainly mature adipocytes and progenitors. New accumulating recent evidences bring the tumor-surrounding adipose tissue into the light as a key component of breast cancer progression. The purpose of this review is to emphasize the role that adipose tissue might play by locally affecting breast cancer cell behavior and subsequent clinical consequences arising from this dialog. Two particular clinical aspects are addressed: obesity that was identified as an independent negative prognostic factor in breast cancer and the oncological safety of autologous fat transfer used in reconstructive surgery for breast cancer patients. This is preceded by the overall description of adipose tissue composition and function with special emphasis on the specificity of adipose depots and the species differences, key experimental aspects that need to be taken in account when cancer is considered. Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Successful human long-term application of in situ bone tissue engineering

              Tissue Engineering (TE) and Regenerative Medicine (RM) have gained much popularity because of the tremendous prospects for the care of patients with tissue and organ defects. To overcome the common problem of donor-site morbidity of standard autologous bone grafts, we successfully combined tissue engineering techniques for the first time with the arteriovenous loop model to generate vascularized large bone grafts. We present two cases of large bone defects after debridement of an osteomyelitis. One of the defects was localized in the radius and one in the tibia. For osseus reconstruction, arteriovenous loops were created as vascular axis, which were placed in the bony defects. In case 1, the bone generation was achieved using cancellous bone from the iliac crest and fibrin glue and in case 2 using a clinically approved β-tricalciumphosphate/hydroxyapatite (HA), fibrin glue and directly auto-transplanted bone marrow aspirate from the iliac crest. The following post-operative courses were uneventful. The final examinations took place after 36 and 72 months after the initial operations. Computer tomogrphy (CT), membrane resonance imaging (MRI) and doppler ultrasound revealed patent arterio-venous (AV) loops in the bone grafts as well as completely healed bone defects. The patients were pain-free with normal ranges of motion. This is the first study demonstrating successfully axially vascularized in situ tissue engineered bone generation in large bone defects in a clinical scenario using the arteriovenous loop model without creation of a significant donor-site defect utilizing TE and RM techniques in human patients with long-term stability.
                Bookmark

                Author and article information

                Journal
                J Cell Mol Med
                J. Cell. Mol. Med
                10.1111/(ISSN)1582-4934
                JCMM
                Journal of Cellular and Molecular Medicine
                John Wiley and Sons Inc. (Hoboken )
                1582-1838
                1582-4934
                28 September 2015
                December 2015
                : 19
                : 12 ( doiID: 10.1111/jcmm.2015.19.issue-12 )
                : 2827-2831
                Affiliations
                [ 1 ] Department of Plastic and Reconstructive Surgery Union HospitalHuazhong Science & Technology University Wuhan HubeiChina
                [ 2 ] Department of Plastic and Hand Surgery and Laboratory for Tissue Engineering and Regenerative Medicine University Hospital ErlangenFriedrich Alexander University Erlangen‐Nuernberg FAUGermany
                Author notes
                [*] [* ] Correspondence to: Jiaming SUN

                E‐mail: sunjm1592@ 123456sina.com

                Article
                JCMM12673
                10.1111/jcmm.12673
                4687699
                26416346
                9198ed9d-55e7-4f3f-8aab-052fb527692b
                © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 16 December 2014
                : 03 August 2015
                Page count
                Pages: 5
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 81071579
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                jcmm12673
                December 2015
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.7.2 mode:remove_FC converted:22.12.2015

                Molecular medicine
                adscs,cytokeratin 18,cytokeratin 19,hbl‐100
                Molecular medicine
                adscs, cytokeratin 18, cytokeratin 19, hbl‐100

                Comments

                Comment on this article